

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
City of Hope Orange County is part of one of the largest and most advanced cancer research and treatment organizations in the United States. City of Hope Orange County’s advanced, integrated cancer care network includes a 72-acre academic research campus in Irvine - home to City of Hope Orange County Lennar Foundation Cancer Center and Orange County’s only cancer specialty hospital - as well as five clinical locations. Patients benefit from the expertise of world-renowned physicians who solely focus on preventing, treating and curing cancer, breakthrough acute and outpatient care, access to more than 700 clinical trials a year and groundbreaking technology. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work.
The Department of Medicine at City of Hope is seeking applications for a full-time Non-Invasive Cardiologist for our Irvine, CA campus. The Division of Cardiology provides expertise in clinical cardio-oncology and cardiac imaging, including a full array of noninvasive cardiovascular imaging, including a full array of noninvasive cardiovascular imaging services to assist with the surveillance of cardiac function and diagnosis of heart disease. Based upon our areas of clinical expertise and our basic, translational and clinical research programs, the International Cardio-Oncology Society has recognized City of Hope as a Center of Excellence in the field of Cardio-Oncology.
We collaborate with our surgeons and anesthesiologists to offer preoperative risk assessments and clinical optimization before major surgery. The emerging field of cardio-oncology is becoming increasingly important, and our Division works closely with all Departments to provide effective, evidence-based care. Position Higlights
Position Benefits:
· Excellent benefits package, including a generous retirement contribution plan
Relocation assistance may be available
· Base Salary Range: $320,000 - $345,000 (Assistant Clinical to Clinical Professor levels). The range listed is exclusively for base compensation for full-time employment and does not include incentive compensation or benefits. Actual compensation will be adjusted for experience, training, hospital/community need and other factors.
Benefits information:City of Hope Medical Group Benefits
Please note: City of Hope is committed to a safe and transparent hiring experience. Please be aware that scammers may attempt to impersonate our organization through fake job postings, emails or interviews.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, Orange County, California, campus, a network of clinical care locations across Southern California and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
City of Hope is an equal opportunity employer.